TuHURA Biosciences HURA
NASDAQ HURA
$2.00 -0.22 (-9.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Accumulated Depreciation (2021 - 2026)

TuHURA Biosciences (HURA) posted quarterly Accumulated Depreciation of $2.2 million for Q1 2026, up 3.84% year-over-year from $2.1 million in Q1 2025, and up 1.09% quarter-over-quarter from $2.2 million in Q4 2025.

TuHURA Biosciences (HURA) Accumulated Depreciation (2021 - 2026) Analysis & Trends

TuHURA Biosciences' Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $2.2 million for Q1 2026.

  • In Q1 2026, Accumulated Depreciation rose 3.84% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 3.84% YoY), while the FY2025 annual figure was $2.2 million, up 3.41% from the prior year.
  • Accumulated Depreciation for Q1 2026 stood at $2.2 million, up from $2.2 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $2.2 million in Q1 2026, with the low at $2.0 million in Q4 2023.
  • The 4-year median for Accumulated Depreciation is $2.1 million (2025), against an average of $2.1 million.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation climbed 5.92% in 2024, then advanced 3.41% in 2025.
  • TuHURA Biosciences' Accumulated Depreciation stood at $2.0 million in 2023, then gained by 5.92% to $2.1 million in 2024, then grew by 3.41% to $2.2 million in 2025, then rose by 1.09% to $2.2 million in 2026.
  • Business Quant data shows HURA's Accumulated Depreciation at $2.2 million in Q1 2026, $2.2 million in Q4 2025, and $2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 TuHURA Biosciences 37.61 Mn 37.61 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.18 Mn
Dec 31, 2025 2.16 Mn
Sep 30, 2025 2.14 Mn
Jun 30, 2025 2.11 Mn
Mar 31, 2025 2.10 Mn
Dec 31, 2024 2.09 Mn
Dec 31, 2023 1.97 Mn
Mar 31, 2021 15,000.00